Paper154122
Natural inhibitors of fibrinolysis.
Aoki N. Prog Cardiovasc Dis, 1979. Cited by 62 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Natural inhibitors of fibrinolysis. Papers, record 154122. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/154122
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifibrinolytic Agents | Major topic |
| Blood Coagulation Disorders | Major topic |
| Blood Coagulation Factors | Major topic |
| Fibrinolysis | Major topic |
| Animals | |
| Disseminated Intravascular Coagulation | |
| Embolism | |
| Female | |
| Fibrinolysin | |
| Haplorhini | |
| Humans | |
| Kidney Diseases | |
| Liver | |
| Plasminogen | |
| Pregnancy | |
| Protease Inhibitors | |
| Rabbits | |
| Thrombophlebitis |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,199,538 | Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7199538 | PubMed |
| 7,018,088 | Thrombosis: its role and prevention in cardiovascular events-Part II. | West J Med | 1981 | https://conductscience.org/library/papers/7018088 | PubMed |
| 6,448,870 | Natural inhibitors of fibrinolysis. | J Clin Pathol Suppl (R Coll Pathol) | 1980 | https://conductscience.org/library/papers/6448870 | PubMed |
| 6,444,305 | Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6444305 | PubMed |
| 6,291,058 | Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6291058 | PubMed |
| 3,166,140 | Organization of the human alpha 2-plasmin inhibitor gene. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/3166140 | PubMed |
| 2,496,145 | Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence. | J Clin Invest | 1989 | https://conductscience.org/library/papers/2496145 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/154122
GET https://conductscience.org/api/papers/v1/154122/authors